International Cancer Cluster Showcase 2025
​- a satellite event to Bio Int. Convention
​"ICCS goes ATMP", June 16th in Boston
ICCS has been a satellite event to BIO International Convention since 2012. Organizing partners from North American and European Innovation Hubs team up to highlight recent innovations from their regions. 

For the 2025 Edition we developed a new format focusing on cell- and gene therapies targeting cancer. A group of distinguished international experts will share their perspectives on emerging science and how to accelerate the path towards clinical implementation. They will focus on novel partnerships addressing existing hurdles and pave the way for effective and affordable novel treatments. The panel discussion is complemented by a pitch session where up to 10 emerging CGT companies from European and US hubs will present their technologies and assets and receive expert feedback they can build on.

​During previous ICCS editions we preselected 20+ emerging companies each year to introduce their innovations in short pitches. The pitch session was complemented by a networking part. Up to 250 dedicated high-level representatives from the international oncology community gathered during BIO for this compact and effective event. Invitations go out to the joint and comprehensive international oncology network including BD and R&D executives from global pharma and biotech companies, investors, academic centers, start-ups and incubators.
Portfolios of previous ICCS events may be found at  ICCS ARCHIVE
About ICCS
  • Compact and focused event organized as annual satellite event to BIO Int. Convention since 2012
  • Hosted by European and North American partners from oncology innovation hubs presenting their ecosystems and oncology pipelines
  • Selected oncology start-ups and scale-ups present emerging technologies and partnering opportunities to decision makers from the Pharma and the investment community
Who should attend?
  • Scouting, Business Development and Licensing Executives from Global Pharma and Biotech
  • Investors
  • Start-ups and biotechs developing novel therapeutics, diagnostics and digital solutions for cancer patients.
  • Researchers and clinicians from academic medical centers.​
ICCS 2025 sponsors
Organizers: